The journey of Takeda’s gout med Uloric—which turned rocky in recent years—has come to an end in the U.S. | Following some ...

Reduce CV Event Risk with Urate-Lowering Therapy for Gout, suggests a study published in The Lancet Rheumatology.Researchers ...

New Phase III data for AstraZeneca's gout drug lesinurad have backed its efficacy and seem to address earlier concerns about its safety. Last year, AZ reported the results of the Phase III LIGHT ...

Among patients with gout in the US, Black individuals and those living in the South were associated with reduced adherence to allopurinol.

Takeda has ended the manufacturing and supply of its gout drug Uloric in the US market as more patients turn to generic ...

The drugs listed are in alphabetical order. Bendamustine hydrochloride injection: Apotex on Jan. 27 reported the discontinuation of both the 25 mg and 100 mg presentations of bendamustine ...

XORTX’s presentation will be recorded and available after the conference on the Company’s website. About XORTX Therapeutics Inc.

What we eat plays a huge role in maintaining our health. Many health problems stem from our diet and daily habits. High uric ...

New research shows diabetes medication SGLT-2 inhibitors lower dementia risk by up to 35%, offering hope for millions ...

Medscape Medical News, March 22, 2010 Progress in Pharmacotherapy of Gout New data on the efficacy and safety of approved and emerging drugs for gout are summarized. Current Opinion in ...

Learn how diabetes medications could revolutionize stroke prevention and enhance heart and brain health with breakthrough ...